Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Nutrien Sees IBD RS Rating Rise To 72

In a welcome move, Nutrien saw its Relative Strength Rating improve from 69 to 72 on Wednesday.

When To Sell Stocks To Lock In Profits And Minimize Losses

IBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks compares to other publicly traded companies.

History shows that the best-performing stocks tend to have an RS Rating north of 80 as they begin their biggest runs. See if Nutrien can continue to show renewed price strength and hit that benchmark.

Nutrien is building a consolidation with a 65.08 buy point. See if it can clear the breakout price in volume at least 40% above average.

Top and bottom line growth moved higher last quarter. Earnings were up 13%, compared to -76% in the prior report. Revenue increased from -5% to 3%.

Nutrien holds the No. 6 rank among its peers in the Chemicals-Agriculture industry group. CVR Partners, CF Industries Holdings and Sociedad Quimica ADR are among the top 5 highly rated stocks within the group.

This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.

RELATED:

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.